// App-Quantinova.ai

: Exome-wide rare variant analysis of Alzheimer’s disease biomarkers: the EMIF-AD multimodal biomarker discovery study

Researchers

Presenter

  • Alexander Neumann

Principal Investigators

  • Michelle Vangoidsenhoven

  • Fahri Küçükali

  • Stephanie J. B. Vos

  • Mara ten Kate

  • Frederik Barkhof

  • Henrik Zetterberg

  • Lars Bertram

  • Pieter Jelle Visser

  • Christine Van Broeckhoven

  • Kristel Sleegers

Medical Centers

  • Amsterdam UMC

  • VU Medical Centre

  • VIB Center for Molecular Neurology, VIB

  • Alzheimer Centrum Limburg, Maastricht University

  • UK Dementia Research Institute

  • University CollegeLondon, UK

  • University of Gothenburg,

  • Amsterdam UMC, location VUmc

  • University of Antwerp

  • University of Lubeck,

  • VIB Center for Molecular Neurology, VIB

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • UCL Institute of Neurology, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Transcription factor Maf

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved